FDA Inspection 1336638 — CMIC CMO Co., Ltd. Nishine Plant
The FDA completed an inspection of CMIC CMO Co., Ltd. Nishine Plant on Aug 7, 2026 in Hachimantai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 7, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hachimantai (Japan)